Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

" adderall ambien KPA obtained exclusive U. in September, 2008. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital.

.


NewsA Level

(KPA), a privately-held specialty pharmaceutical company headquartered in Montgomery, AL, announced today that the U. We believe Cambia addresses these needs and will be a valuable addition to physicians' migraine armamentarium. A privately held company, KPA focuses its efforts on the acquisition, development, licensing and marketing of pharmaceutical products. is a specialty pharmaceutical company engaged in research, development and manufacture of Aversion(R) (abuse deterrent) Technology product candidates and other innovative abuse deterrent technologies. About King Pharmaceuticals, Inc. King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company.S..